This approach has demonstrated unique advantages in addressing complex diseases such as cancer, neurodegenerative disorders, and cardiovascular diseases [8, 9]
doi: 10.1021/acsnano.8b09573
Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially filling in for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness
Why This Matters Traditional painkillers like opioids work by blocking pain signals
Moreover, BPC 157 injections significantly improved knee pain and function, regardless of the underlying condition